Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2025 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de service
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to The Report
Fundraising

New Age Meats

New Age Meats Raises $25M in Series A

2018
Founded
20+
Employees
San Francisco, CA
Updated June 22, 2021
2 min read

Quick Facts

New Age Meats Raises $25M in Series A


New Age Meats has successfully raised $25M in a Series A at a $90M valuation led by Draper Associates, Clear Current Capital.


Company Overview


New Age Meats is a FoodTech company headquartered in San Francisco, CA, founded in 2018 with 20+ employees.


Cell-cultured sausage and pork


Fundraising Details


  • Amount Raised: $25M
  • Round Type: Series A
  • Valuation: $90M
  • Date: 2021-06-22
  • Investors: Draper Associates, Clear Current Capital

About New Age Meats


Cell-cultured sausage and pork The company is positioned in the FoodTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: San Francisco, CA
  • Founded: 2018
  • Team Size: 20+
  • Industry: FoodTech

What This Means


This funding round demonstrates strong investor confidence in New Age Meats's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The FoodTech sector continues to attract significant investment as companies innovate to meet evolving market demands. New Age Meats's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $90M valuation marks an important milestone for New Age Meats, positioning the company among notable players in the FoodTech industry.


Looking Ahead


With this new capital, New Age Meats is well-positioned to execute on its growth strategy and continue building innovative solutions in the FoodTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2021-06-22. For more information about New Age Meats, visit their headquarters at San Francisco, CA.

Topics

Fundraising(2912)FoodTechSeries ANew Age Meats

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million